Enzymatic and cellular study of a serotonin N-acetyltransferase phosphopantetheine-based prodrug

Yousang Hwang, Surajit Ganguly, Anthony K. Ho, David C. Klein, Philip A. Cole

Research output: Contribution to journalArticle

Abstract

Serotonin N-acetyltransferase (arylalkylamine N-acetyltransferase, AANAT) regulates the daily rhythm in the production of melatonin and is therefore an attractive target for pharmacologic modulation of the synthesis of this hormone. Previously prepared bisubstrate analogs show potent inhibition of AANAT but have unfavorable pharmacokinetic properties due to the presence of phosphate groups which prevents transfer across the plasma membrane. Here, we examine a bis-pivaloyloxymethylene (POM)-tryptamine-phosphopantetheine prodrug (2) and its biotransformations in vitro by homogenates and pineal cells. Compound 2 is an efficient porcine liver esterase substrate for POM cleavage in vitro although cyclization of the phosphate moiety is a potential side product. Tryptamine phosphopantetheine (3) is converted to tryptamine-coenzyme A (CoA) bisubstrate analog (1) by human phosphoribosyl pyrophosphate amidotransferase (PPAT) and dephosphocoenzyme A kinase (DPCK) in vitro. Compound 2 was found to inhibit melatonin production in rat pineal cell culture. It was also found that the POM groups are readily removed to generate 3; however, further processing to tryptamine-CoA (1) is much slower in pineal extracts or cell culture. Implications for CoA prodrug development based on the strategy used here are discussed.

Original languageEnglish (US)
Pages (from-to)2147-2155
Number of pages9
JournalBioorganic and Medicinal Chemistry
Volume15
Issue number5
DOIs
StatePublished - Mar 1 2007

Keywords

  • Enzyme
  • Inhibition
  • Melatonin
  • POM
  • Pantetheine
  • Prodrug

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Enzymatic and cellular study of a serotonin N-acetyltransferase phosphopantetheine-based prodrug'. Together they form a unique fingerprint.

  • Cite this